172 related articles for article (PubMed ID: 35388133)
1. The prognostic value of the Naples prognostic score for patients with non-small-cell lung cancer.
Peng SM; Ren JJ; Yu N; Xu JY; Chen GC; Li X; Li DP; Yang J; Li ZN; Zhang YS; Qin LQ
Sci Rep; 2022 Apr; 12(1):5782. PubMed ID: 35388133
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Preoperative Naples Prognostic Score in Patients With Non-Small Cell Lung Cancer.
Ren D; Wu W; Zhao Q; Zhang X; Duan G
Technol Cancer Res Treat; 2022; 21():15330338221129447. PubMed ID: 36254549
[No Abstract] [Full Text] [Related]
3. Naples Prognostic Score as a novel prognostic prediction tool in video-assisted thoracoscopic surgery for early-stage lung cancer: a propensity score matching study.
Li S; Wang H; Yang Z; Zhao L; Lv W; Du H; Che G; Liu L
Surg Endosc; 2021 Jul; 35(7):3679-3697. PubMed ID: 32748268
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of Naples prognostic score in non-small-cell lung cancer patients with brain metastases.
Xuan J; Peng J; Wang S; Cai Y
Future Oncol; 2022 Apr; 18(13):1545-1555. PubMed ID: 35107367
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Predictive Values of Naples Prognostic Score in Patients with Unresectable Stage III Non-Small Cell Lung Cancer.
Guo D; Liu J; Li Y; Li C; Liu Q; Ji S; Zhu S
J Inflamm Res; 2021; 14():6129-6141. PubMed ID: 34848991
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
Wang J; Liu Y; Mi X; Shao M; Liu L
Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of prognostic nutritional index in advanced (stage IIIB/IV) non-small cell lung cancer patients.
Li XL; Yao ZH; Wan YY; Mou XY; Ni YH; Sun EL; Zhang D; Lin DJ
Neoplasma; 2019 Nov; 66(6):971-977. PubMed ID: 31390870
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score.
Galizia G; Auricchio A; de Vita F; Cardella F; Mabilia A; Basile N; Orditura M; Lieto E
Ann Ital Chir; 2019; 90():404-416. PubMed ID: 31814602
[TBL] [Abstract][Full Text] [Related]
9. [Value of surgery for stage IIIa non-small cell lung cancer].
Liu H; Wang M; Hu K; Xu Y; Ma M; Zhong W; Zhao J; Li L; Wang H
Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):639-45. PubMed ID: 24345488
[TBL] [Abstract][Full Text] [Related]
10. Naples Prognostic Score is an Independent Prognostic Factor in Patients with Small Cell Lung Cancer and Nomogram Predictive Model Established.
Chen S; Liu S; Xu S; Cao S; Han Z; Kong L; Ren D; Duan G
J Inflamm Res; 2022; 15():3719-3731. PubMed ID: 35789664
[TBL] [Abstract][Full Text] [Related]
11. Naples prognostic score is an independent prognostic factor in patients with operable endometrial cancer: Results from a retrospective cohort study.
Li Q; Cong R; Wang Y; Kong F; Ma J; Wu Q; Ma X
Gynecol Oncol; 2021 Jan; 160(1):91-98. PubMed ID: 33081984
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of the SUVmax Measured From FDG PET and Neutrophil-to-lymphocyte Ratio Improves Prediction of Clinical Outcomes in Patients With Locally Advanced Non-small-cell Lung Cancer.
Guo D; Jin F; Jing W; Li M; Chen D; Zou B; Jiang G; Fu L; Zhu H; Kong L; Wu J; Yu J; Yue J
Clin Lung Cancer; 2019 Nov; 20(6):412-419. PubMed ID: 31300364
[TBL] [Abstract][Full Text] [Related]
13. Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy.
Zhao K; Wang C; Shi F; Huang Y; Ma L; Li M; Song Y
BMC Cancer; 2021 Jan; 21(1):66. PubMed ID: 33446134
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Naples prognostic score in predicting survival for small cell lung cancer patients treated with chemoradiotherapy.
Liu J; Wang Z; Liu G; Liu Z; Lu H; Ji S
Ann Med; 2023; 55(2):2242254. PubMed ID: 37552770
[TBL] [Abstract][Full Text] [Related]
15. Preoperative increased systemic immune-inflammation index predicts poor prognosis in patients with operable non-small cell lung cancer.
Gao Y; Zhang H; Li Y; Wang D; Ma Y; Chen Q
Clin Chim Acta; 2018 Sep; 484():272-277. PubMed ID: 29860033
[TBL] [Abstract][Full Text] [Related]
16. The value of the preoperative Naples prognostic score in predicting prognosis in gallbladder cancer surgery patients.
Yang J; Lv L; Zhao F; Mei X; Zhou H; Yu F
World J Surg Oncol; 2023 Sep; 21(1):303. PubMed ID: 37743468
[TBL] [Abstract][Full Text] [Related]
17. Naples Prognostic Score as an Independent Predictor of Survival Outcomes for Resected Locally Advanced Non-Small Cell Lung Cancer Patients After Neoadjuvant Treatment.
Zou Z; Li J; Ji X; Wang T; Chen Q; Liu Z; Ji S
J Inflamm Res; 2023; 16():793-807. PubMed ID: 36860794
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of AJCC TNM Staging 7th edition in limited-stage small cell lung cancer: validation in 437 patients].
Zhang W; Zhu H; Zhou Z; Feng Q; Chen D; Zhang H; Xiao Z; Wang L
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):917-22. PubMed ID: 26887621
[TBL] [Abstract][Full Text] [Related]
19. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.
Lin JH; Lin D; Xu L; Wang Q; Hu HH; Xu HP; He ZY
Oncotarget; 2017 Jan; 8(2):3412-3421. PubMed ID: 27926500
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer.
Vanhove K; Mesotten L; Heylen M; Derwael R; Louis E; Adriaensens P; Thomeer M; Boellaard R
Cancer Treat Res Commun; 2018; 15():7-12. PubMed ID: 30207286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
